InfoChachkie

DECEMBER 8, 2011

I began our discussion by asking Brad what motivated him to co-author Venture Deals , rather than continuing to share venture capitalists’ secrets via his Ask The VC blog. Writing a book is very different from writing a blog. In my review of the book, my biggest concern was the rather elevated list price of $49.95.

Venture Capital 224

Venture Capital Writing Entrepreneur Blogging 224

Both Sides of the Table

APRIL 30, 2011

In the IAB study that revealed the graph above, brand advertisers indicated that their number one objective in online advertising was “creating awareness&# followed by “creating purchase intent&# or “likelihood to recommend&# the product. Give people massive price increases on most media and they’ll abandon it.

Advertising 352

Advertising Media Social Media Screening 352

Both Sides of the Table

OCTOBER 22, 2010

He studied the errors that other people had made and tried to improve on them. He wanted to create awareness for himself to generate marketing buzz and demand and then get the retail stores to pay wholesales prices for his cds. He’s holding back for now, but he’s clearly studying what’s going on in technology.

Entrepreneur 356

Entrepreneur Venture Capital Startup Email 356

Both Sides of the Table

MAY 7, 2011

Sometime around 2003/04 my technology team turned me on to “Spolsky on Software&# a periodic newsletter served up blog style from Joel Spolsky of FogCreek Software, a maker of bug-tracking software. Blogs weren’t popularized yet so it was an oddity for me to read the founder of a software company spewing out advice.

Software Review 285

Software Review Software Blogging Startup 285

Xconomy

APRIL 26, 2019

Biogen’s (NASDAQ: BIIB ) earnings call this week was the first since its Alzheimer’s drug aducanumab failed in a Phase 3 study and eviscerated the company’s shares. But it’s earnings season now, so some of them don’t have much choice. CEO Michel Vounatsos acknowledged the drug didn’t work.

News 94

News Pricing Study Company 94

Both Sides of the Table

SEPTEMBER 6, 2010

We set our sites on our IPO price and then worked back to our current valuation and showed potential employees what we thought they could earn (with all legal caveats) if the company was successful. I’ve said versions of it on this blog before so I hope it’s not too repetitive. I think you will. This is mostly true.

Startup 294

Startup Sales Venture Capital Slides 294

InfoChachkie

OCTOBER 3, 2011

Like music, movies and blog entries, startups are a remix of that which came before. As noted in What Color Are Your Elephant’s Sunglasses , the large majority of research and development expenditures are spent on product features (e.g., smaller, faster, cheaper, lighter, etc.)

Startup 255

Startup High Tech SaaS .Net 255

Xconomy

JULY 2, 2018

A paper published last week in the journal JAMA Oncology makes the case that one such test, Oncotype DX AR-V7 Nucleus Detect, might be worth its $3,980 price tag. But how useful are they? Earlier this year, the federal insurance program Medicare sent positive signals about coverage but hasn’t made a final decision.)

Guide 81

Guide Study San Diego Journal 81

Both Sides of the Table

JANUARY 12, 2014

The starting point of product IS marketing, which is what a lot of young entrepreneurs that never studied business don’t realize. Product is simply about defining a physical good or service that would be valued by consumers of the product more than existing alternatives based on functionality, quality and/or price.

Marketing 379

Marketing Startup SEM SEO 379

Xconomy

DECEMBER 21, 2018

Before you fly off, or drive, or simply unplug, check out our preview of what could be next year’s top clinical studies; the tumult in big pharma’s on again-off again relationship with consumer healthcare; big names on the move in the nation’s capital; and a flurry of year-end deals.

Pricing 73

Pricing Sales Study News 73

Both Sides of the Table

JULY 23, 2013

Every time I approached Network Solutions (or any technical group in Accenture) they wrote me off as “a business guy” since I studied economics and was on the Accenture “business track.” When I decided to start blogging again (I had done so as an entrepreneur) I thought about how to brand myself.

Technical Advisors 385

Technical Advisors Marketing Startup Venture Capital 385

Xconomy

MARCH 17, 2017

The data, from a massive study of more than 27,000 patients, come at a time when drug and healthcare prices are a top U.S. political issue, and pricey new cholesterol drugs have been a key battleground.

Study 87

Study Pricing Sales Journal 87

Xconomy

NOVEMBER 26, 2019

La Jolla Pharmaceutical is turning its focus to its lone FDA-approved product and another one in the pipeline after an experimental drug for a rare blood disease failed a late-stage study. The company said an interim analysis showed no benefit compared to the placebo.

Pricing 63

Pricing Study Product San Diego 63

Both Sides of the Table

MAY 13, 2018

This goes into the heart of my controversial blog post (coming soon! Come back to this blog over the next 2 weeks and I’ll explain. Sometimes I encourage teams to create new analysis on cohorts, future revenue projections, competitor reviews, pricing studies, etc. can I get 20 minutes to swing by” is a good way to engage.

Venture Capital 332

Venture Capital Funding Startup Sales 332

Xconomy

JUNE 21, 2018

The San Francisco company priced its IPO late Tuesday, selling 6.25 Eidos will use the cash to fund studies of AG10 , a drug in mid-stage testing for transthyretin (TTR) amyloidosis, a progressive and fatal condition caused by the. The first was Eidos Therapeutics (NASDAQ: EIDX ), which raised $106 million in its stock market debut.

Study 72

Study Startup Pricing Funding 72

Tech Zulu Event

MARCH 2, 2013

Providers make their pricing model transparent and easily available on the web, so it’s simple to calculate the cost savings of the cloud. Providers make their pricing model transparent and easily available on the web, so it’s simple to calculate the cost savings of the cloud.

Cloud Computing 85

Cloud Computing Marketing CIO Organization 85

Xconomy

AUGUST 11, 2016

government has ambitious plans for a long-term health study with one million Americans, and one of the world’s most powerful tech companies has a big part to play, including the storage of all the data on its “cloud” servers. It even has a price guide.). million, with potentially $72 million over five years.

PMI 40

PMI Study Google Research 40

socalTECH

OCTOBER 14, 2011

One, is it makes it easy for businesses to embed that video on their own website, on blogs, and Facebook, and they can also link to that video on their Google Places page. There was a recent study which showed that adding a video makes it 53 times more likely that you'll have a Google first page search result.

Networking 150

Networking Search Engine Optimization Product Startup 150

Tech Zulu Event

NOVEMBER 18, 2011

Typically entrepreneurs doubt themselves because they undervalue their offerings, but it isn’t about creating a product, setting a price and hoping people will buy. Valu e and Exp erience versus Price and Product. Now study the event organizer. Blogs and Forums. The best place to find a directory of blogs is AllTop.

Customer 85

Customer Custom Marketing SEO 85

Xconomy

MAY 24, 2019

Patients, doctors, family members, and drug-price watchdogs continued to wait for the expected approval of Zolgensma , a Novartis (NYSE: NVS ) gene therapy for the rare inherited disease spinal muscular atrophy. Originally developed at a children’s hospital in Ohio , Zolgensma will be a litmus test for the nascent field.

Pricing 86

Pricing Marketing Develop Development 86

Xconomy

APRIL 6, 2018

The FDA didn’t smile upon a big submission of depression studies from Alkermes, while those fighting liver disease got a mixed slate of data as a big medical conference looms. There were plenty of policy and drug-price headlines, Read more » Reprints | Share: After the deals, we’ll move on to data.

Study 55

Study Pricing Conference Marketing 55

Xconomy

JULY 29, 2020

Thrive Earlier Detection, one of the companies vying to be the first to commercialize a blood test that can uncover cases of cancer before symptoms arise, has raised $257 million and announced plans to evaluate its CancerSEEK test in a registrational study.

San Diego 87

San Diego Study Capital Invest 87

Tech Zulu Event

JULY 18, 2011

Andrea: Anybody who’s looking for clothes, shoes or accessories can come to our site and put up a post of what they’re looking for with the size, price range, etc., If you are referring to the blog post about being a mom and a CEO, studies have shown that women are far better multi-taskers than men.

Startup 99

Startup Social Media Media Sites 99

Xconomy

APRIL 21, 2017

Our own reporting focused this week on the fallout from high drug prices, with a look at the frustration of families whose children have had trouble gaining access to the first drug ever approved for the rare spinal muscular atrophy.

Study 49

Study Pricing News Google 49

Xconomy

SEPTEMBER 1, 2017

billion, the price Gilead Sciences is paying for Kite Pharma and its cancer-fighting cell therapy pipeline. The far-out idea of reprogramming a patient’s immune cells to fight cancer, known as CAR-T, entered the mainstream this week, and two numbers highlight the tale. The first is $11.9

Pricing 74

Pricing Ideas San Diego Study 74

Xconomy

DECEMBER 20, 2016

San Diego-based Acadia (NASDAQ: ACAD ) reported that patients treated in an exploratory study with its drug pimavanserin showed a statistically significant reduction in psychosis compared against a group given a placebo. Investors cheered the news, boosting Acadia’s stock price 13.6 percent to $28.88 in trading Tuesday morning.

San Diego 40

San Diego Statistics Study News 40

Xconomy

SEPTEMBER 7, 2016

Retrophin , the drug developer founded by controversial former biotech executive Martin Shkreli, has posted positive results from a midstage study for its treatment for a rare kidney disease. This time, he increased the price from $13.50 The Leerink analysts placed a $32 per share price target on the stock. to $30 apiece.

San Diego 40

San Diego Pricing Study Journal 40

Xconomy

JULY 18, 2016

In early trading Monday, Evoke’s (NASDAQ: EVOK ) stock price was down 72 percent to $3.02 Evoke’s late-stage study failed to show a significant benefit to the drug, EVK-001, versus placebo at all 41 of the sites that tested it nationally. per share as of 11:30 a.m. in New York.

Study 40

Study Sites News Research 40

AeA Los Angeles Council

APRIL 25, 2008

billion dollars (at the current price of $3.33) if everyone with the potential to telework did so just 1.6 A study by the Telework Coaltion surveyed 13 organizations that collectively had more than 77,000 teleworkers. I have employees that telework… and I am actually composing this blog from home! days a week.

AeA 40

AeA IBM IBM Tool 40

Xconomy

SEPTEMBER 16, 2016

New documents came to light that showed the sugar industry paid for studies downplaying the ties between sugar and heart disease. Meanwhile, there was yet another twist in the ongoing Duchenne muscular dystrophy drama, more biotech buyouts, new startups, and the filing of a long anticipated IPO.

Research 40

Research Pricing News Report 40

Xconomy

AUGUST 19, 2016

Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. . —The FDA last summer approved two new cholesterol fighting drugs known as PCSK9 inhibitors, but so far the market has rejected them, resulting in paltry sales.

Technical Review 40

Technical Review Patents .Net Study 40

Tech Zulu Event

APRIL 18, 2016

Many retailers report $100,000 is the minimum price of entry. The price of a retail app varies depending on the developer and features; nevertheless, it’s a big number. App development agency NN4M writes in its blog that customer conversion rates are 1.75 This is certainly on the high end of the spectrum.

Mobile 40

Mobile Sites Customer Custom 40

Xconomy

AUGUST 12, 2016

Lilly will continue the study, but the news puts distance between abemaciclib and two similar, rival cancer drugs from Pfizer (palbociclib (Ibrance)) and Novartis (ribociclib)). Both Pfizer and Novartis stopped Phase 3 trials of their drugs early because they were clearly benefitting breast cancer patients. . In the U.S.,

Google 40

Google Technical Review News Research 40

Xconomy

JANUARY 25, 2019

In a week of big personnel moves, none was more surprising than Editas Medicine CEO Katrine Bosley’s departure.

Guide 63

Guide Patents Startup Develop 63

Xconomy

AUGUST 31, 2018

Before you head out for the final summer getaway, catch up on the week’s headlines. Pfizer upped the ante in the field of transthyretin amyloidosis (ATTR) treatment, where competition to treat the rare disease has grown increasingly complex.

News 49

News Startup Competition San Diego 49

Both Sides of the Table

OCTOBER 10, 2011

The big price increase : 5 out of 5 stars. Some customer segments value the DVD business and these may be more price sensitive. They might be willing to pay higher prices (and perhaps not an “all you can eat” price but a “pay as you go” price per film). A blog post! No, probably not.

Netflix 287

Netflix Customer Custom Pricing 287

Both Sides of the Table

AUGUST 14, 2009

I recently wrote a post on angel financing covering the topic of convertible notes but I realized I was thinking about the issue more from investor perspective and a very narrow topic of how to price the round. If you can’t get product released and validated then do user studies. I am always an advocate of setting a price.

Angel 291

Angel Funding Venture Capital Startup 291